Compounds > tyrosine

tyrosine and 18f-fluoroethyl-l-tyrosine

tyrosine has been researched along with 18f-fluoroethyl-l-tyrosine in 112 studies

Research

Studies (112)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's100 (89.29)24.3611
2020's12 (10.71)2.80

Authors

AuthorsStudies
Coenen, HH; Hamacher, K; Langen, KJ; Oros-Peusquens, AM; Reifenberger, G; Salber, D; Shah, NJ; Stoffels, G1
Auf, G; Blechschmidt, C; Brenner, W; Denecke, T; Geworski, L; Nyuyki, F; Plotkin, M; Stockhammer, F1
Coenen, HH; Eble, MJ; Holy, R; Kaiser, HJ; Klotz, J; Langen, KJ; Nussen, S; Pinkawa, M; Piroth, MD; Stoffels, G1
Coenen, HH; Ewelt, C; Felsberg, J; Floeth, FW; Langen, KJ; Reifenberger, G; Sabel, M; Steiger, HJ; Stoffels, G; Stummer, W1
Egensperger, R; Eigenbrod, S; Geisler, J; Hartmann, C; Herms, J; Kreth, FW; Kreth, S; Kretzschmar, HA; Kunz, M; la Fougere, C; Linn, J; Lutz, J; Pöpperl, G; Thon, N; Tonn, JC; von Deimling, A1
Bartenstein, P; Belka, C; Ganswindt, U; Garny, S; Geisler, J; Kreth, FW; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB; Siefert, A; Suchorska, B; Tonn, JC1
Ewelt, C; Felsberg, J; Floeth, FW; Langen, KJ; Sabel, M; Steiger, HJ; Stoffels, G; Stummer, W1
Anile, C; Baum, RP; Calcagni, ML; Galli, G; Giordano, A; Niesen, A; Taralli, S1
Bruehlmeier, M; Hefti, M; Hundsberger, T; Nitzsche, EU; Roelcke, U1
Buck, A; Dunet, V; Prior, JO; Rossier, C; Stupp, R1
Bouvet, V; Tam, PH; Wang, M; Wuest, F; Wuest, M1
Heinzel, A; Langen, KJ; Müller, D; Stock, S1
Armbruster, L; Bartenstein, P; Cumming, P; Eigenbrod, S; Graute, V; Jansen, NL; Kreth, FW; la Fougère, C; Lutz, J; Suchorska, B; Tonn, JC1
Coenen, HH; Eble, MJ; Filss, CP; Fink, GR; Galldiks, N; Holy, R; Kaiser, HJ; Langen, KJ; Nolte, KW; Pinkawa, M; Piroth, MD; Stoffels, G1
Bartenstein, P; Belka, C; Eigenbrod, S; Ganswindt, U; Geisler, J; Kreth, FW; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB; Suchorska, B; Tonn, JC1
Buck, AK; Buck, D; Drzezga, A; Förschler, A; Hemmer, B; Korn, T; Krause, BJ; Lapa, C; Nessler, S; Schuster, T; Stadelmann, C; Vollmar, P; Wester, HJ; Zimmer, C1
Coenen, HH; Fink, GR; Galldiks, N; Langen, KJ; Rapp, M; Sabel, M; Shah, NJ; Stoffels, G1
Beez, T; Coenen, HH; Ewelt, C; Felsberg, J; Floeth, FW; Galldiks, N; Heinzel, A; Langen, KJ; Rapp, M; Reifenberger, G; Sabel, M; Steiger, HJ; Stoffels, G1
Engelbach, JA; Garbow, JR; Huang, C; Mach, RH; McConathy, J; Piwnica-Worms, D; Rich, KM; Sai, KK; Yuan, L; Zhou, D1
Blaum, M; Galldiks, N; Heinzel, A; Langen, KJ; Mottaghy, FM; Müller, D; Verburg, FA1
Kung, HF; Lieberman, BP; Ploessl, K; Wang, L1
Afshar-Oromieh, A; Combs, SE; Debus, J; Giesel, FL; Haberkorn, U; Kratochwil, C; Leotta, K; Rieken, S1
Buck, AK; Einsele, H; Jörg, G; Knop, S; Lapa, C; Lückerath, K; Rosenwald, A; Samnick, S; Spahmann, A1
Bartenstein, P; Drexler, M; Eigenbrod, S; Jansen, NL; Kreth, FW; la Fougère, C; Niyazi, M; Schmid-Tannwald, C; Schnell, O; Suchorska, B; Thon, N; Tonn, JC; Wenter, V; Zwergal, A1
Förschler, A; Förster, S; Gempt, J; Grams, AE; Meyer, B; Ringel, F; Ryang, YM; Schlegel, J; Soehngen, E; Zimmer, C1
Bloch, J; Dunet, V; Lhermitte, B; Maeder, P; Meuli, R; Nicod-Lalonde, M; Pollo, C; Prior, JO; Stupp, R1
Kjaer, A; Kristoffersen, K; Lassen, U; Madsen, J; Michaelsen, SR; Nedergaard, MK; Poulsen, HS; Stockhausen, MT1
Förster, S; Gempt, J; Hüttinger, S; Nekolla, S; Pyka, T; Ringel, F; Schwaiger, M; van Marwick, S; Wester, HJ1
Bilger, A; Bittner, MI; Firat, E; Grosu, AL; Meyer, PT; Milanović, D; Niedermann, G; Weber, WA; Wiedenmann, N1
Chung, D; Currie, GM; Kiat, H; Magnussen, J; Ong, YY; Saunders, C; Trifunovic, M; Wilkinson, M; Witte, K1
Bluemel, C; Buck, AK; Czernin, J; Ernestus, RI; Herrmann, K; Homola, GA; Kessler, AF; Lapa, C; Linsenmann, T; Löhr, M; Monoranu, CM; Samnick, S1
Bolcaen, J; Boterberg, T; De Vos Pharm, F; Deblaere, K; Decrock, E; Descamps, B; Goethals, I; Kalala, JP; Leybaert, L; Van den Broecke, C; Vanhove, C1
Egensperger, R; Eigenbrod, S; Giese, A; Herms, J; Jansen, NL; Kreth, FW; Kreth, S; Kretzschmar, H; Kunz, M; la Fougère, C; Lemke, L; Lutz, J; Thon, N; Tonn, JC; Weller, M1
Avril, N; Hoimes, C; Hu, L; Lee, Z; Muzic, R; Sher, A; Valls, L1
Bartenstein, P; Eigenbrod, S; Jansen, NL; Kreth, FW; la Fougère, C; Niyazi, M; Schmid-Tannwald, C; Suchorska, B; Todica, A; Tonn, JC; Wenter, V1
Eigenbrod, S; Jansen, NL; Janssen, H; Kreth, FW; Kretzschmar, H; la Fougere, C; Linn, J; Pöpperl, G; Simon, M; Suchorska, B; Tonn, JC; Weller, M1
Kamli, AA; Kollias, SS; Purohit, B1
Broholm, H; El Ali, H; Kjaer, A; Lassen, U; Michaelsen, SR; Nedergaard, MK; Poulsen, HS; Stockhausen, MT; Urup, T1
Franci, X; Genon, JL; Giacomelli, F; Kuci, S; Lemaire, C; Libert, L; Luxen, A1
de Nijs, R; Dyssegaard, A; Feng, L; Fischer, W; Guilloteau, D; Jensen, P; Knudsen, GM; Larsen, VA; Law, I; Mikkelsen, JD; Pinborg, LH; Svarer, C; Thomsen, G1
Bette, S; Förster, S; Gempt, J; Hiob, D; Meyer, B; Pyka, T; Ringel, F; Schlegel, J; Wester, HJ1
Bette, S; Buchmann, N; Förschler, A; Förster, S; Gempt, J; Meyer, B; Pyka, T; Ringel, F; Ryang, YM; Wester, HJ1
Hansen, AE; Henriksen, OM; Larsen, VA; Larsson, HBW; Law, I; Muhic, A; Poulsen, HS1
Albert, NL; Bartenstein, P; Brendel, M; la Fougère, C; Mille, E; Schmid-Tannwald, C; Suchorska, B; Todica, A; Tonn, JC; Wenter, V; Winkelmann, I1
Bacher-Stier, C; Berndt, M; Bullich, S; Chin, FT; Dinkelborg, LM; Fels, LM; Friebe, M; Gambhir, SS; Gekeler, V; Hoehne, A; Iagaru, AH; Keu, KV; Koglin, N; Kumar, M; Mittra, ES; Moon, DH; Mosci, C; Mueller, A; Schmitt-Willich, H; Stephens, AW1
Bauer, JS; Buchmann, N; Delbridge, C; Gempt, J; Kläsner, B; Krause, BJ; Meyer, B; Pyka, T; Ringel, F1
Erler, J; Kjaer, A; Lassen, U; Michaelsen, SR; Nedergaard, MK; Perryman, L; Poulsen, HS; Stockhausen, MT1
Byrne, AT; Dicker, P; Faber, C; Hermann, S; Jacobs, AH; Jarzabek, MA; Klasen, T; Kopka, K; Murray, DW; O'Brien, D; O'Halloran, PJ; Prehn, JH; Schäfers, M; Schwegmann, K; Viel, T; Wachsmuth, L; Wagner, S1
Andersson, M; Johansson, L; Leide-Svegborn, S; Mattsson, S; Minarik, D1
Andratschke, N; Brown, M; Gulden-Sala, W; Roth, P; Stupp, R; Weller, M1
Albert, NL; Bartenstein, P; Fendler, WP; Schmid-Tannwald, C; Schüller, U; Schweisthal, F; Suchorska, B; Tonn, JC; Unterrainer, M; Wenter, V1
Harat, M; Makarewicz, R; Małkowski, B1
Ebner, Y; Egger, B; Fritsch, B; Galldiks, N; Grosse, J; Hau, P; Hellwig, D; Hutterer, M; Langen, KJ; McCoy, M; Menhart, K; Meyer, PT; Proescholdt, M; Riemenschneider, MJ; Roelcke, U; Schröder, M; Stockhammer, G; Trinka, E; Urbach, H; Wendl, C; Willuweit, A1
Kameyama, M; Umeda-Kameyama, Y1
Bolcaen, J; Boterberg, T; De Vos, F; Deblaere, K; Descamps, B; Goethals, I; Kalala, JP; Lybaert, K; Moerman, L; Van den Broecke, C; Vanhove, C1
Bandelow, U; Ermert, J; Filss, C; Galldiks, N; Langen, KJ; Lohmann, P; Lübke, JH; Oliveira, D; Shah, NJ; Stegmayr, C; Willuweit, A1
Costa, J; Engelholm, S; Engelholm, SA; Law, I; Moller, S; Munck Af Rosenschold, P; Poulsen, HS1
Cai, H; Guastella, AR; Juhász, C; Klinger, NV; Mangner, TJ; Michelhaugh, SK; Mittal, S; Muzik, O; Polin, LA; Xin, Y; Zhang, S1
Ceccon, G; Filss, CP; Galldiks, N; Kamp, MA; Langen, KJ; Lohmann, P; Neumaier, B; Rapp, M; Sabel, M; Shah, NJ; Stegmayr, C; Stoffels, G1
Förster, S; Gempt, J; Göttler, J; Kaczmarz, S; Kluge, A; Lukas, M; Meyer, B; Mustafa, M; Preibisch, C; Pyka, T; Ringel, F; Schwaiger, M; Zimmer, C1
Chatelut, E; Concordet, D; de Mey, J; de Ridder, M; Duerinck, J; Everaert, H; Gandia, P; Heemskerk, J; Jaudet, C; Neyns, B; Vanbinst, AM1
Bundschuh, RA; Essler, M; Fimmers, R; Gaertner, FC; Glas, M; Hattingen, E; Herrlinger, U; Kebir, S; Khurshid, Z; Scheffler, B1
Ceccon, G; Dunkl, V; Ermert, J; Fink, GR; Galldiks, N; Judov, N; Kops, ER; Langen, KJ; Meyer, PT; Rapp, M; Shah, NJ; Stoffels, G; Tscherpel, C1
Abualhaj, B; Attarwala, AA; Büsing, K; Glatting, G; Molina, F; Ong, M; Weng, G1
Fellner, FA; Gabriel, M; Hatzl, M; Röper-Kelmayr, JC1
Filss, C; Galldiks, N; Heinzel, A; Langen, KJ; Lohmann, P; Mottaghy, FM; Neumaier, B; Stegmayr, C; Stoffels, G; Willuweit, A1
Fouquet, JP; Lebel, R; Lepage, M; Richard, MA1
Langen, KJ; Loução, R; Oros-Peusquens, AM; Shah, NJ; Zimmermann, M1
Back, M; Bailey, D; Brazier, D; Chan, D; Jaymanne, DT; Kaushal, S; Schembri, G; Wheeler, H1
Albert, NL; Bartenstein, P; Biczok, A; Drexler, M; Giese, A; Schüller, U; Suchorska, B; Tonn, JC; Unterrainer, M; Weller, M1
Bumes, E; Galldiks, N; Grosse, J; Hau, P; Hellwig, D; Hutterer, M; Langen, KJ; Riemenschneider, MJ1
Aprile, C; Buroni, FE; Corbella, F; Facoetti, A; Hodolic, M; Lodola, L; Nano, R; Pasi, F; Persico, MG1
Giovanella, L; Muoio, B; Treglia, G1
Atwa, ST; Eltaoudy, MH; Omar, WM; Shama, SA; Siddiq, IS1
Bashir, A; Brennum, J; Broholm, H; Law, I1
Gao, L; Liang, F; Tao, L; Weng, J; Xu, W; Yu, J; Zhang, J; Zheng, J1
Blanc-Durand, P; Itti, E; Prior, JO; Schaefer, N; Van Der Gucht, A1
Gielen, GH; Giordano, FA; Glas, M; Herrlinger, U; Kebir, S; Lazaridis, L; Rauschenbach, L; Schäfer, N; Scheffler, B; Tzaridis, T1
Albert, NL; Egensperger, R; Kreth, FW; Kreth, S; Kunz, M; la Fougere, C; Lutz, J; Schüller, U; Thon, N; Tonn, JC; Unterrainer, M1
Blanc-Durand, P; Bloch, J; Brouland, JP; Dunet, V; Langen, KJ; Nicod-Lalonde, M; Prior, JO; Schaefer, N; Van Der Gucht, A; Verger, A1
Bauer, EK; Ceccon, G; Dunkl, V; Fink, GR; Galldiks, N; Henriksen, OM; Langen, KJ; Law, I; Lohmann, P; Muhic, A; Poulsen, HS; Schmidt, M; Shah, NJ; Steger, J; Stoffels, G; Tscherpel, C1
Allinson, K; Bielik, R; Booth, T; Brindle, KM; Jones, J; Lewis, DY; Lyons, SK; Mair, R; Soloviev, D; Wright, A1
Albatly, AA; Barbagallo, M; Buck, A; Hayward-Könnecke, HK; Huellner, MW; Kollias, SS; Schreiner, S1
Albert, NL; Bartenstein, P; Diekmann, C; Dorostkar, M; Kümpfel, T; Tonn, JC; Unterrainer, M; Vettermann, FJ1
Bauer, EK; Ceccon, G; Fink, GR; Galldiks, N; Langen, KJ; Lipke, K; Lohmann, P; Neumaier, B; Shah, NJ; Stavrinou, P; Werner, JM1
Belanger, AP; Dubey, S; George, E; Horky, L; Huang, RY; Kesari, S; Kijewski, MF; Park, MA; Reardon, DA; Wen, PY1
Albert, NL; Berding, G; Felsberg, J; Forbrig, R; Galldiks, N; Hasselblatt, M; la Fougère, C; Reifenberger, G; Schittenhelm, J; Schüller, U; Vettermann, FJ; Weis, J1
Abdulla, DSY; Brandes, V; Büttner, R; Drzezga, A; Fischer, R; Galldiks, N; Grau, S; Kobe, C; Kunze, S; Merkelbach-Bruse, S; Michels, S; Nogova, L; Persigehl, T; Riedel, R; Ruge, M; Scheffler, M; Wolf, J1
Albers, J; Amthauer, H; Furth, C; Lukas, M; Rogasch, JMM; Steinkrüger, FL; Wedel, F1
Bellu, L; Bertin, D; Caccese, M; Cuppari, L; Evangelista, L; Lombardi, G; Reccia, P; Zagonel, V1
Bolcaen, J; De Lombaerde, S; De Vos, F; Deblaere, K; Descamps, B; Goeman, J; Goethals, I; Hallaert, G; Hulpia, F; Kersemans, K; Van Calenbergh, S; Van den Broecke, C; Van der Eycken, J; Vanhove, C; Verhoeven, J1
Alberts, E; Angelikopoulos, P; Combs, SE; Diehl, C; Hadjidoukas, P; Koumoutsakos, P; Lipkova, J; Lowengrub, J; Menze, B; Preibisch, C; Pyka, T; Van Leemput, K; Wiestler, B; Wu, S1
Brändlein, S; Buck, AK; Ernestus, RI; Kertels, O; Kessler, AF; Lapa, C; Linsenmann, T; Löhr, M; Mihovilovic, MI; Monoranu, CM; Samnick, S; Stolzenburg, A1
Bolcaen, J; Boterberg, T; De Meulenaere, V; De Vos, F; Deblaere, K; Descamps, B; Donche, S; Goethals, I; Kalala, JP; Kersemans, K; Van den Broecke, C; Vanhove, C; Verhoeven, J1
Borggrefe, J; Ceccon, G; Fink, GR; Galldiks, N; Kabbasch, C; Langen, KJ; Lichtenstein, T; Lohmann, P; Shah, NJ; Stoffels, G; Werner, JM1
Alexiou, GA; Fotopoulos, AD; Jabbour, P; Katsanos, AH; Kyritsis, AP; Sioka, C1
Koch, R; Müther, M; Schwindt, W; Sporns, P; Stummer, W; Weckesser, M1
Albert, NL; Bartenstein, P; Belka, C; Corradini, S; Fleischmann, DF; Förster, S; la Fougère, C; Niyazi, M; Rottler, M; Schwaiger, M; Siepmann, T; Unterrainer, M1
Bohner, G; Brenner, W; Hamm, B; Lohmeier, J; Makowski, MR; Siebert, E1
Andrée Larsen, V; Bashir, A; Broholm, H; Grunnet, K; Law, I; Mathilde Jacobsen, S; Mølby Henriksen, O; Møller, S; Skjøth-Rasmussen, J; Skovgaard Poulsen, H; Urup, T1
Akhoundova, D; Andratschke, N; Bankel, L; Curioni-Fontecedro, A; Förster, R; Hiltbrunner, S; Hüllner, M; Kollias, S; Kraft, J; Lee, SY; Mader, C; Rushing, EJ; Schwanhäusser, B; Treyer, V1
Abgral, R; Auberger, B; Basse, V; Bourhis, D; Dissaux, G; El Kabbaj, O; Kassoul, A; Magro, E; Querellou, S; Salaun, PY; Schick, U1
Coenen, HH; Ermert, J; Filß, C; Galldiks, N; Heinzel, A; Langen, KJ; Lohmann, P; Mottaghy, FM; Stegmayr, C; Stoffels, G; Willuweit, A1
Esposito, G; Fischer, DR; Fuenfgeld, B; Huellner, MW; Kaufmann, PA; Mächler, P; Rushing, EJ; Stolzmann, P1
Abdulla, DSY; Baues, C; Ceccon, G; Celik, E; Fink, GR; Galldiks, N; Hüllner, M; Kocher, M; Kreuzberg, N; Landsberg, J; Langen, KJ; Lohmann, P; Marnitz, S; Mauch, C; Ruge, MI; Scheffler, M; Schlaak, M; Schweinsberg, V; Stoffels, G; Tonn, JC; Trommer, M; Weller, M; Werner, JM; Wolf, J; Wolpert, F1
Caparrotti, F; Conen, K; Hottinger, AF; Hundsberger, T; Ochsenbein, A; Remonda, L; Roelcke, U; Roth, P; Tabatabai, G; von Moos, R; Weller, J; Weller, M; Wirsching, HG1
Boada, F; Nuyts, J; Rezaei, A; Rigie, D; Schramm, G; Shepherd, T; Vahle, T; Van Laere, K1
Albert, NL; Bartenstein, P; Belka, C; Fleischmann, DF; Forbrig, R; Herms, J; Niyazi, M; Ruf, V; Rupprecht, R; Tonn, JC; Unterrainer, M; Vettermann, FJ1
Antoch, G; Bundschuh, RA; Colletti, PM; Forsting, M; Glas, M; Herrlinger, U; Herrmann, K; Kebir, S; Keyvani, K; Kleinschnitz, C; Lazaridis, L; Milia, A; Pierscianek, D; Rauschenbach, L; Rubello, D; Schäfer, N; Scheffler, B; Schmidt, T; Stuschke, M; Sure, U; Umutlu, L; Weber, M1
Baltas, D; Carles, M; Eckert, F; Grosu, AL; Mix, M; Niyazi, M; Popp, I; Schimek-Jasch, T; Starke, MM; Urbach, H1
Bourhis, D; Dissaux, B; Dissaux, G; Querellou, S; Schick, U1
Black, D; Kaneko, S; Schipmann, S; Sporns, P; Stummer, W; Suero Molina, E1

Reviews

10 review(s) available for tyrosine and 18f-fluoroethyl-l-tyrosine

ArticleYear
Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:2

    Topics: Animals; Brain Neoplasms; Diagnosis, Differential; Glioma; Humans; Positron-Emission Tomography; Quality Control; Tyrosine

2012
Imaging of adult brainstem gliomas.
    European journal of radiology, 2015, Volume: 84, Issue:4

    Topics: Adult; Brain Stem; Brain Stem Neoplasms; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2015
[Gliomas – What I Have to Know in ten Questions].
    Praxis, 2016, Mar-16, Volume: 105, Issue:6

    Topics: Anticoagulants; Anticonvulsants; Brain Neoplasms; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Glioblastoma; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Oligodendroglioma; Positron-Emission Tomography; Tyrosine

2016
Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[
    Methods (San Diego, Calif.), 2017, 11-01, Volume: 130

    Topics: Animals; Brain Neoplasms; Humans; Positron-Emission Tomography; Protein Transport; Tyrosine

2017
Methods for molecular imaging of brain tumours in a hybrid MR-PET context: Water content, T
    Methods (San Diego, Calif.), 2017, 11-01, Volume: 130

    Topics: Animals; Brain Neoplasms; Diffusion; Humans; Magnetic Resonance Imaging; Molecular Imaging; Positron-Emission Tomography; Tyrosine; Water

2017
Recent Developments of 18F-FET PET in Neuro-oncology.
    Current medicinal chemistry, 2018, Volume: 25, Issue:26

    Topics: Brain Neoplasms; Humans; Positron-Emission Tomography; Tyrosine

2018
Accuracy of
    World neurosurgery, 2018, Volume: 114

    Topics: Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation Injuries; Retrospective Studies; Tyrosine

2018
Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.
    Current radiopharmaceuticals, 2019, Volume: 12, Issue:3

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tyrosine

2019
Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:11

    Topics: Brain Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Neoplasm Grading; Positron-Emission Tomography; Tyrosine

2019
Current trends in the use of O-(2-[
    Nuclear medicine and biology, 2021, Volume: 92

    Topics: Animals; Brain Neoplasms; Humans; Tyrosine

2021

Trials

8 trial(s) available for tyrosine and 18f-fluoroethyl-l-tyrosine

ArticleYear
Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:4

    Topics: Adult; Aged; Aminolevulinic Acid; Blood-Brain Barrier; Brain Neoplasms; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Spectrometry, Fluorescence; Tyrosine

2011
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:1

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Tyrosine

2013
Prognostic value of
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2016, Volume: 121, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Dose-Response Relationship, Radiation; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Re-Irradiation; Treatment Outcome; Tumor Burden; Tyrosine

2016
Dynamic 18F-FET PET is a powerful imaging biomarker in gadolinium-negative gliomas.
    Neuro-oncology, 2019, 02-14, Volume: 21, Issue:2

    Topics: Biomarkers, Tumor; Female; Follow-Up Studies; Gadolinium; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Survival Rate; Tyrosine

2019
Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.
    European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:13

    Topics: Adult; Aged; Bevacizumab; Disease Progression; Drug Interactions; Female; Glioblastoma; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis; Treatment Outcome; Tyrosine

2018
Voxel-Wise Analysis of Fluoroethyltyrosine PET and MRI in the Assessment of Recurrent Glioblastoma During Antiangiogenic Therapy.
    AJR. American journal of roentgenology, 2018, Volume: 211, Issue:6

    Topics: Angiogenesis Inhibitors; Bevacizumab; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Tyrosine

2018
Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
    PloS one, 2019, Volume: 14, Issue:7

    Topics: Adolescent; Adult; Aged; Bevacizumab; Brain Neoplasms; Chemoradiotherapy; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Temozolomide; Tumor Burden; Tyrosine

2019
MRI and
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 01-01, Volume: 27, Issue:1

    Topics: Aged; Aged, 80 and over; Bevacizumab; Brain; Brain Neoplasms; Chemoradiotherapy; Female; Glioblastoma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Progression-Free Survival; Radiopharmaceuticals; Tyrosine

2021

Other Studies

94 other study(ies) available for tyrosine and 18f-fluoroethyl-l-tyrosine

ArticleYear
Comparison of O-(2-18F-fluoroethyl)-L-tyrosine and L-3H-methionine uptake in cerebral hematomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:5

    Topics: Animals; Autoradiography; Cerebral Hemorrhage; Collagenases; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Magnetic Resonance Imaging; Male; Methionine; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tyrosine

2010
Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.
    European radiology, 2010, Volume: 20, Issue:10

    Topics: Adult; Aged; Biopsy; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Tyrosine

2010
Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.
    International journal of radiation oncology, biology, physics, 2011, May-01, Volume: 80, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Temozolomide; Tyrosine

2011
Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.
    Neuro-oncology, 2011, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; DNA Methylation; Female; Glioma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Positron-Emission Tomography; Promoter Regions, Genetic; Prospective Studies; Radiopharmaceuticals; Tyrosine; World Health Organization; Young Adult

2011
FET-PET for malignant glioma treatment planning.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2011, Volume: 99, Issue:1

    Topics: Aged; Biopsy; Brain Neoplasms; Contrast Media; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Retrospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine

2011
Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
    Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:7

    Topics: Adult; Aminolevulinic Acid; Biopsy; Brain Neoplasms; Carcinoma; Contrast Media; Female; Fluorescence; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Intraoperative; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted; Tyrosine

2011
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for glioma grading: assessment of individual probability of malignancy.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:10

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Time Factors; Tyrosine; Young Adult

2011
F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:1

    Topics: Adult; Brain Neoplasms; Choline; False Negative Reactions; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine

2012
Microfluidic technology: an economical and versatile approach for the synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET).
    Bioorganic & medicinal chemistry letters, 2012, Mar-15, Volume: 22, Issue:6

    Topics: Animals; Chromatography, High Pressure Liquid; Fluorine Radioisotopes; Half-Life; Isotope Labeling; Mice; Mice, Inbred BALB C; Microfluidics; Neoplasm Transplantation; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tyrosine

2012
Cost-effectiveness analysis of FET PET-guided target selection for the diagnosis of gliomas.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:7

    Topics: Biopsy; Brain Neoplasms; Cost-Benefit Analysis; Decision Trees; Glioma; Humans; Magnetic Resonance Imaging; Monte Carlo Method; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2012
MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:6

    Topics: Biological Transport; Cohort Studies; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Tyrosine

2012
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:7

    Topics: Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Contrast Media; Disease Progression; Disease-Free Survival; Female; Gadolinium; Glioblastoma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neurosurgical Procedures; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Tyrosine

2012
FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2012, Volume: 104, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Chemoradiotherapy; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tumor Suppressor Proteins; Tyrosine

2012
18F-FDG PET detects inflammatory infiltrates in spinal cord experimental autoimmune encephalomyelitis lesions.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:8

    Topics: Animals; Cell Proliferation; Dideoxynucleosides; Encephalomyelitis, Autoimmune, Experimental; Female; Fluorodeoxyglucose F18; Inflammation; Positron-Emission Tomography; Rats; Spinal Cord; Tyrosine

2012
Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Brain Neoplasms; Child; Child, Preschool; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tyrosine

2013
18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:7

    Topics: Alanine; Animals; Brain Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Triazoles; Tyrosine

2013
The use of O-(2-18F-fluoroethyl)-L-tyrosine PET for treatment management of bevacizumab and irinotecan in patients with recurrent high-grade glioma: a cost-effectiveness analysis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:8

    Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Camptothecin; Cost-Benefit Analysis; Decision Trees; Disease-Free Survival; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Monte Carlo Method; Neoplasm Grading; Positron-Emission Tomography; Recurrence; Treatment Outcome; Tyrosine

2013
Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.
    Nuclear medicine and biology, 2014, Volume: 41, Issue:1

    Topics: Amidohydrolases; Animals; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Chemistry Techniques, Synthetic; Dipeptidases; Humans; Hydrolysis; Positron-Emission Tomography; Prodrugs; Rats; Tyrosine

2014
Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.
    Neuro-oncology, 2014, Volume: 16, Issue:3

    Topics: Astrocytoma; Brain Neoplasms; Dihydroxyphenylalanine; Glioblastoma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine

2014
Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Cell Line, Tumor; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Methionine; Multiple Myeloma; Paraproteins; Positron-Emission Tomography; Radioactive Tracers; Statistics, Nonparametric; Tyrosine

2013
Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:2

    Topics: Adult; Astrocytes; Brain Neoplasms; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk; Time Factors; Treatment Outcome; Tyrosine

2014
Multimodal imaging in cerebral gliomas and its neuropathological correlation.
    European journal of radiology, 2014, Volume: 83, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Brain Neoplasms; Diagnosis, Differential; Female; Glioma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine; Young Adult

2014
Combination of MRI and dynamic FET PET for initial glioma grading.
    Nuklearmedizin. Nuclear medicine, 2014, Aug-06, Volume: 53, Issue:4

    Topics: Adult; Brain Neoplasms; Female; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Grading; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine

2014
The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Camptothecin; Cell Line, Tumor; Female; Glioblastoma; Heterografts; Humans; Irinotecan; Mice, Nude; Neuroimaging; Positron-Emission Tomography; Tyrosine

2014
Prediction of glioma recurrence using dynamic ¹⁸F-fluoroethyltyrosine PET.
    AJNR. American journal of neuroradiology, 2014, Volume: 35, Issue:10

    Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tyrosine

2014
FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2014, Volume: 190, Issue:10

    Topics: Adult; Brain Neoplasms; Chloroquine; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Treatment Outcome; Tyrosine

2014
Pituitary incidentaloma found on O-(2-18F-fluoroethyl)-l-tyrosine PET.
    Journal of nuclear medicine technology, 2014, Volume: 42, Issue:3

    Topics: Female; Humans; Incidental Findings; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2014
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Basal Ganglia; Biopsy; Brain; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Recurrence; Tyrosine

2014
(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
    Nuclear medicine and biology, 2015, Volume: 42, Issue:1

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radioactive Tracers; Radiopharmaceuticals; Rats; Recurrence; Tyrosine

2015
Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses.
    International journal of cancer, 2015, May-01, Volume: 136, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Positron-Emission Tomography; Prognosis; Promoter Regions, Genetic; Prospective Studies; Radiopharmaceuticals; Tyrosine; Young Adult

2015
Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.
    Seminars in roentgenology, 2014, Volume: 49, Issue:3

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium DTPA; Humans; Image Enhancement; Indoles; Kidney Neoplasms; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrroles; Radiopharmaceuticals; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine

2014
Prognostic significance of dynamic 18F-FET PET in newly diagnosed astrocytic high-grade glioma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:1

    Topics: Astrocytoma; Biological Transport; Female; Humans; Kinetics; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tyrosine

2015
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.
    Neurology, 2015, Feb-17, Volume: 84, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Longitudinal Studies; Male; Microsurgery; Middle Aged; Neurosurgical Procedures; Positron-Emission Tomography; Prospective Studies; Temozolomide; Treatment Outcome; Tumor Burden; Tyrosine

2015
18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.
    PloS one, 2015, Volume: 10, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Magnetic Resonance Imaging; Membrane Proteins; Mice; Microvessels; Multimodal Imaging; Optical Imaging; Positron-Emission Tomography; RNA, Messenger; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2015
Automated production at the curie level of no-carrier-added 6-[(18)F]fluoro-L-dopa and 2-[(18)F]fluoro-L-tyrosine on a FASTlab synthesizer.
    Journal of labelled compounds & radiopharmaceuticals, 2015, Jun-15, Volume: 58, Issue:7

    Topics: Automation, Laboratory; Chemistry Techniques, Synthetic; Dihydroxyphenylalanine; Radiopharmaceuticals; Tyrosine

2015
TSPO Imaging in Glioblastoma Multiforme: A Direct Comparison Between 123I-CLINDE SPECT, 18F-FET PET, and Gadolinium-Enhanced MR Imaging.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:9

    Topics: Aged; Biomarkers, Tumor; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Female; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Radiopharmaceuticals; Receptors, GABA; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tyrosine

2015
Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:1

    Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies; Survival Analysis; Tumor Burden; Tyrosine

2016
Volumetric Analysis of F-18-FET-PET Imaging for Brain Metastases.
    World neurosurgery, 2015, Volume: 84, Issue:6

    Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tumor Burden; Tyrosine

2015
Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:1

    Topics: Blood Volume; Brain Neoplasms; Feasibility Studies; Glioma; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tumor Burden; Tyrosine

2016
Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:6

    Topics: Diagnosis, Differential; Female; Glioma; Humans; Kinetics; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Reference Standards; Retrospective Studies; ROC Curve; Tyrosine

2016
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Adult; Aged; Animals; Brain Neoplasms; Case-Control Studies; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glioblastoma; Glutamic Acid; Heterografts; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tomography, X-Ray Computed; Tyrosine

2016
(18)F-Fluoroethyl-l-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging.
    World neurosurgery, 2016, Volume: 89

    Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Postoperative Period; Preoperative Period; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tyrosine

2016
Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.
    Nuclear medicine and biology, 2016, Volume: 43, Issue:3

    Topics: Animals; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Dideoxynucleosides; Female; Glioblastoma; HEK293 Cells; Humans; Mice; Microvessels; Positron-Emission Tomography; Survival Analysis; Tyrosine; Vascular Endothelial Growth Factor A

2016
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:9

    Topics: Animals; Bevacizumab; Biological Transport; Biomarkers, Tumor; Cell Line, Tumor; Drug Interactions; Female; Glioblastoma; Humans; Imidazoles; Magnetic Resonance Imaging; Mice; Microvessels; Multimodal Imaging; Phosphoinositide-3 Kinase Inhibitors; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinolines; TOR Serine-Threonine Kinases; Tumor Burden; Tyrosine; Xenograft Model Antitumor Assays

2016
ORGAN DOSES AND EFFECTIVE DOSE FOR FIVE PET RADIOPHARMACEUTICALS.
    Radiation protection dosimetry, 2016, Volume: 169, Issue:1-4

    Topics: Carbon Isotopes; Choline; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Male; Phantoms, Imaging; Positron-Emission Tomography; Raclopride; Radiation Dosage; Radiometry; Radiopharmaceuticals; Software; Stochastic Processes; Tyrosine

2016
Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:8

    Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; False Negative Reactions; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tyrosine; Watchful Waiting; Young Adult

2016
Pre-irradiation tumour volumes defined by MRI and dual time-point FET-PET for the prediction of glioblastoma multiforme recurrence: A prospective study.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2016, Volume: 120, Issue:2

    Topics: Adolescent; Adult; Aged; Disease Progression; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tumor Burden; Tyrosine; Young Adult

2016
Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:1

    Topics: Adult; Aged; Amino Acid Transport Systems; Amino Acids; Biological Transport, Active; Brain Neoplasms; Diagnosis, Differential; Diagnostic Errors; Epilepsy; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine

2017
Strategy based on kinetics of O-(2-[
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:12

    Topics: Brain Neoplasms; Computer Simulation; Glioma; Humans; Image Enhancement; Models, Biological; Neoplasm Grading; Reproducibility of Results; Sensitivity and Specificity; Tyrosine

2016
Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
    PloS one, 2016, Volume: 11, Issue:8

    Topics: Animals; Brain; Cell Line, Tumor; Choline; Diagnosis, Differential; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Kinetics; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity; Tyrosine

2016
Influence of blood-brain barrier permeability on O-(2-
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:3

    Topics: Animals; Antineoplastic Agents, Hormonal; Blood-Brain Barrier; Capillary Permeability; Cell Line, Tumor; Dexamethasone; Glioma; Humans; Male; Radiopharmaceuticals; Rats; Tight Junctions; Tyrosine

2017
Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:2

    Topics: Animals; Biomarkers, Tumor; Brain Neoplasms; Carbon Radioisotopes; Cell Line, Tumor; Female; Humans; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, SCID; Molecular Imaging; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tryptophan; Tyrosine

2017
Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase
    European radiology, 2017, Volume: 27, Issue:7

    Topics: Adolescent; Aged; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiometry; Tyrosine; Young Adult

2017
Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma.
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Cerebral Angiography; Female; Glioma; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2017
Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma.
    Clinical pharmacokinetics, 2017, Volume: 56, Issue:8

    Topics: Aged; Brain Neoplasms; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine

2017
Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma.
    Oncotarget, 2017, Jan-31, Volume: 8, Issue:5

    Topics: Adult; Aged; Brain Neoplasms; Cluster Analysis; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Pilot Projects; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Time Factors; Treatment Outcome; Tyrosine; Unsupervised Machine Learning

2017
The use of O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cord.
    Neuro-oncology, 2017, 05-01, Volume: 19, Issue:5

    Topics: Adolescent; Adult; Aged; Brain Stem Neoplasms; Child; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Spinal Cord Neoplasms; Tyrosine; Young Adult

2017
Comparison of five cluster validity indices performance in brain [
    Medical physics, 2017, Volume: 44, Issue:1

    Topics: Algorithms; Brain; Diagnosis, Differential; Glioma; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Recurrence; Reproducibility of Results; Tyrosine

2017
18F-Fluorocholine, 18F-FDG, and 18F-Fluoroethyl Tyrosine PET/CT in Parathyroid Cancer.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:6

    Topics: Aged; Choline; Female; Fluorodeoxyglucose F18; Humans; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Thyroidectomy; Tyrosine

2017
Determination of an Optimal Pharmacokinetic Model of
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:8

    Topics: Animals; Brain Neoplasms; Kinetics; Male; Models, Biological; Positron-Emission Tomography; Rats; Tissue Distribution; Tyrosine

2017
Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.
    Journal of medical imaging and radiation oncology, 2018, Volume: 62, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Treatment Outcome; Tyrosine

2018
Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma.
    Neuro-oncology, 2018, 01-22, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Child; Chromosomes, Human, Pair 19; Female; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Positron-Emission Tomography; Prognosis; Time Factors; Tyrosine; Young Adult

2018
AIDS-Related Central Nervous System Toxoplasmosis With Increased 18F-Fluoroethyl-L-Tyrosine Amino Acid PET Uptake Due to LAT1/2 Expression of Inflammatory Cells.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Adaptor Proteins, Signal Transducing; Adult; Biological Transport; Brain Neoplasms; Diagnosis, Differential; Female; Gene Expression Regulation; Humans; Inflammation; Large Neutral Amino Acid-Transporter 1; Positron-Emission Tomography; Toxoplasmosis, Cerebral; Tyrosine

2017
Uptake of
    Contrast media & molecular imaging, 2017, Volume: 2017

    Topics: Carbon; Cell Line, Tumor; Choline; Diagnosis, Differential; Glioblastoma; Humans; Ions; Neoplasm Metastasis; Photons; Tyrosine

2017
Radiosynthesis and modified quality control of O-(2-[
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2018, Volume: 133

    Topics: Brain Neoplasms; Equipment Design; Fluorine Radioisotopes; Humans; Positron-Emission Tomography; Quality Control; Radiopharmaceuticals; Technology, Radiologic; Tyrosine

2018
The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    Journal of neurosurgery, 2018, 04-06, Volume: 130, Issue:2

    Topics: Adult; Biomarkers, Tumor; Brain Neoplasms; Cell Transformation, Neoplastic; Female; Glioma; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Oligodendroglia; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Treatment Outcome; Tyrosine

2018
Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study.
    PloS one, 2018, Volume: 13, Issue:4

    Topics: Glioma; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Neural Networks, Computer; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tyrosine

2018
Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2018, Volume: 53

    Topics: Aged; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Glioblastoma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine

2018
Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.
    PloS one, 2018, Volume: 13, Issue:6

    Topics: Adult; Biomarkers, Tumor; Cluster Analysis; Female; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Isocitrate Dehydrogenase; Kaplan-Meier Estimate; Male; Middle Aged; Mutation; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Tyrosine

2018
[
    Theranostics, 2018, Volume: 8, Issue:14

    Topics: Administration, Intravenous; Animals; Brain Neoplasms; Disease Models, Animal; Glioma; Heterografts; Histocytochemistry; Luminescent Measurements; Neoplasm Transplantation; Rats; Surgery, Computer-Assisted; Treatment Outcome; Tyrosine

2018
Value of 18F-FET PET in Patients With Suspected Tumefactive Demyelinating Disease-Preliminary Experience From a Retrospective Analysis.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:11

    Topics: Adult; Aged; Demyelinating Diseases; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Tyrosine; Young Adult

2018
Neurosarcoidosis Mimics High-Grade Glioma in Dynamic 18F-FET PET Due to LAT Expression.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:11

    Topics: Brain Neoplasms; Central Nervous System Diseases; Diagnosis, Differential; Glioma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine

2018
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.
    European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Tumor Burden; Tyrosine

2019
Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:12

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Female; Glioma; Histones; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2018
Monitoring Treatment Response to Erlotinib in EGFR-mutated Non-small-cell Lung Cancer Brain Metastases Using Serial O-(2-[
    Clinical lung cancer, 2019, Volume: 20, Issue:2

    Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Mutation; Positron-Emission Tomography; Tyrosine

2019
Point Spread Function Reconstruction for Integrated 18F-FET PET/MRI in Patients With Glioma: Does It Affect SUVs and Respective Tumor-to-Background Ratios?
    Clinical nuclear medicine, 2019, Volume: 44, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Retrospective Studies; Tyrosine; Young Adult

2019
New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.
    Scientific reports, 2019, 02-27, Volume: 9, Issue:1

    Topics: Animals; Apoptosis; Cell Proliferation; Female; Glioblastoma; Humans; Large Neutral Amino Acid-Transporter 1; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tumor Cells, Cultured; Tyrosine; Xenograft Model Antitumor Assays

2019
Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans, and Bayesian Inference.
    IEEE transactions on medical imaging, 2019, Volume: 38, Issue:8

    Topics: Bayes Theorem; Brain; Brain Neoplasms; Glioblastoma; Humans; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine; Radiotherapy Planning, Computer-Assisted; Tyrosine

2019
Prognostic Value of O-(2-[
    Molecular imaging and biology, 2019, Volume: 21, Issue:6

    Topics: Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Tyrosine; World Health Organization

2019
Technical feasibility of [
    Radiation oncology (London, England), 2019, May-30, Volume: 14, Issue:1

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Feasibility Studies; Female; Glioblastoma; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Rats, Inbred F344; Treatment Outcome; Tumor Burden; Tyrosine

2019
Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI.
    European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Diffusion; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Survival Analysis; Tyrosine; Young Adult

2019
5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.
    Neurosurgery, 2019, 12-01, Volume: 85, Issue:6

    Topics: Aminolevulinic Acid; Brain Neoplasms; Gadolinium; Glioblastoma; Humans; Optical Imaging; Positron-Emission Tomography; Tyrosine

2019
Quantitative biparametric analysis of hybrid
    Scientific reports, 2019, 10-10, Volume: 9, Issue:1

    Topics: Adult; Area Under Curve; Brain Neoplasms; Central Nervous System Neoplasms; False Positive Reactions; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Treatment Outcome; Tyrosine

2019
Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET).
    Neuro-oncology, 2019, 12-17, Volume: 21, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Female; Follow-Up Studies; Glioblastoma; Humans; Immunotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tyrosine; Young Adult

2019
18F-FET PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non-Small Cell Lung Cancer.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:2

    Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tyrosine

2020
Prognostic value of 18F-FET PET/CT in newly diagnosed WHO 2016 high-grade glioma.
    Medicine, 2020, Volume: 99, Issue:5

    Topics: Contrast Media; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tyrosine

2020
Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination.
    PloS one, 2020, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Biological Transport; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Reference Values; Tyrosine; Young Adult

2020
Treatment Monitoring of Immunotherapy and Targeted Therapy Using
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021, Volume: 62, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Combined Modality Therapy; Disease Progression; Female; Humans; Immunotherapy; Lung Neoplasms; Male; Melanoma; Middle Aged; Molecular Targeted Therapy; Retrospective Studies; Treatment Outcome; Tyrosine

2021
Approximating anatomically-guided PET reconstruction in image space using a convolutional neural network.
    NeuroImage, 2021, 01-01, Volume: 224

    Topics: Brain; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Neural Networks, Computer; Nortropanes; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2021
Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:12

    Topics: Adult; Biological Transport; Biopsy; Brain Neoplasms; Carbazoles; Glioma; Histones; Humans; Male; Mutation; Positron-Emission Tomography; Tyrosine

2020
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography.
    Journal of neuro-oncology, 2021, Volume: 152, Issue:2

    Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Machine Learning; Male; Middle Aged; Multiple Sclerosis; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine

2021
FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
    Radiation oncology (London, England), 2021, Mar-03, Volume: 16, Issue:1

    Topics: Adult; Aged; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Re-Irradiation; Treatment Outcome; Tyrosine

2021
18F-FET PET/CT in Early Subventricular Zone Recurrence of Adult Glioblastoma.
    Clinical nuclear medicine, 2021, 06-01, Volume: 46, Issue:6

    Topics: Adult; Brain Neoplasms; Female; Glioblastoma; Humans; Lateral Ventricles; Positron Emission Tomography Computed Tomography; Recurrence; Tyrosine

2021
Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
    Journal of neurosurgery, 2022, Jan-01, Volume: 136, Issue:1

    Topics: Adult; Aminolevulinic Acid; Brain Neoplasms; Chromosome Deletion; Female; Fluorescence; Glioma; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Photosensitizing Agents; Positron-Emission Tomography; Protoporphyrins; Radiopharmaceuticals; Spectrometry, Fluorescence; Tyrosine

2022